Chemical Formula: C26H52N6O11S

Chemical Formula C26H52N6O11S

Found 4 metabolite its formula value is C26H52N6O11S

MLS000028713-01!DEFEROXAMINE MESYLATE

MLS000028713-01!DEFEROXAMINE MESYLATE

C26H52N6O11S (656.3414602)


   

DEFEROXAMINE MESYLATE_major

DEFEROXAMINE MESYLATE_major

C26H52N6O11S (656.3414602)


   

Deferoxamine mesylate

Deferoxamine (mesylate)

C26H52N6O11S (656.3414602)


D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Deferoxamine mesylate (Deferoxamine B mesylate) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine mesylate upregulates HIF-1α levels with good antioxidant activity. Deferoxamine mesylate also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine mesylate can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].

   

N-{5-[acetyl(hydroxy)amino]pentyl}-N-(5-{4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanamido}pentyl)-N-hydroxybutanediamide methanesulfonate

N-{5-[acetyl(hydroxy)amino]pentyl}-N-(5-{4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanamido}pentyl)-N-hydroxybutanediamide methanesulfonate

C26H52N6O11S (656.3414602)


D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents